ES2155854T3 - Procedimiento de produccion de proteinas de fusion que comprende fragmentos de scfv con la ayuda de un molde transformado. - Google Patents
Procedimiento de produccion de proteinas de fusion que comprende fragmentos de scfv con la ayuda de un molde transformado.Info
- Publication number
- ES2155854T3 ES2155854T3 ES94920443T ES94920443T ES2155854T3 ES 2155854 T3 ES2155854 T3 ES 2155854T3 ES 94920443 T ES94920443 T ES 94920443T ES 94920443 T ES94920443 T ES 94920443T ES 2155854 T3 ES2155854 T3 ES 2155854T3
- Authority
- ES
- Spain
- Prior art keywords
- gene
- aspergillus
- present
- scfv
- mould
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UN PROCESO PARA PRODUCIR PROTEINAS DE FUSION QUE COMPRENDEN FRAGMENTOS DE SCFV MEDIANTE UN MOLDE DE ASPERGILLUS TRANSFORMADO QUE CONTIENE UNA SECUENCIA DE ADN QUE CODIFICA EL FRAGMENTO SCFV BAJO EL CONTROL DE AL MENOS UNA EXPRESION Y/O UNA REGION DE REGULACION DE SECRECION DERIVADA DE UN MOLDE SELECCIONADO DEL GRUPO QUE CONSTA DE SECUENCIAS PROMOTORAS, SECUENCIAS TERMINADORAS Y SECUENCIAS DE ADN DE CODIFICACION DE SECUENCIA DE SEÑAL O DERIVADOS FUNCIONALES O ANALOGOS DE LAS MISMAS. TAL REGION DE REGULACION PUEDE DERIVARSE DEL GEN ENDOXILANASA II (GEN EXIA) DE ASPERGILLUS NIGER VAR. AWAMORI PRESENTE EN EL PLASMIDO PAW14B O PUEDE SER LA COMBINACION DE UN PROMOTOR Y UNA SECUENCIA DE ADN DE CODIFICACION DE SECUENCIA DE SEÑAL DERIVADA DE UN GEN DE GLUCOMILASA EX ASPERGILLUS MAS UNA SECUENCIA TERMINADORA DE UN GEN TRPC EX ASPERGILLUS. PREFERIBLEMENTE SE PRODUCE UNA PROTEINA DE FUSION QUE COMPRENDE "PROTEINA DE MOLDE SEGREGADA - (KEX2 -) SCFV". ADEMAS SE PROPORCIONAN NUEVOS PRODUCTOS QUE COMPRENDEN UN FRAGMENTO DE SCFV O PRODUCTO DE FUSION DEL MISMO, COMPOSICIONES, POR EJEMPLO, PRODUCTOS DE CONSUMIDOR, QUE CONTIENEN TANTO NUEVOS COMO ANTIGUOS PRODUCTOS ASI PRODUCIDOS. PREFERIBLEMENTE EL FRAGMENTO SCFV RECONOCE UN COMPUESTO PRESENTE EN EL ECOSISTEMA HUMANO, COMO MICROORGANISMOS O ENZIMAS. TALES COMPUESTOS PUEDEN ESTAR PRESENTES EN LA CAVIDAD ORAL, POR EJEMPLO, IMPLICADOS EN LA FORMACION DE PLACA, CARIES, GINGIVITIS, ENFERMEDADES PERIODONTALES, O MAL ALIENTO, O EN LA PIEL HUMANA, POR EJEMPLO, IMPLICADOS EN LA FORMACION DE MAL OLOR, INFLAMACION O PERDIDA DE PELO, O PUEDE SER UNA HORMONA, POR EJEMPLO, HCG.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93201660 | 1993-06-09 | ||
EP93201661 | 1993-06-09 | ||
EP93201706 | 1993-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2155854T3 true ES2155854T3 (es) | 2001-06-01 |
Family
ID=27235312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94920443T Expired - Lifetime ES2155854T3 (es) | 1993-06-09 | 1994-06-09 | Procedimiento de produccion de proteinas de fusion que comprende fragmentos de scfv con la ayuda de un molde transformado. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0702721B1 (es) |
JP (1) | JPH08511160A (es) |
AT (1) | ATE198490T1 (es) |
AU (1) | AU7123494A (es) |
CA (1) | CA2162878A1 (es) |
DE (1) | DE69426527T2 (es) |
DK (1) | DK0702721T3 (es) |
ES (1) | ES2155854T3 (es) |
FI (1) | FI114870B (es) |
WO (1) | WO1994029457A2 (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9504344D0 (en) * | 1995-03-03 | 1995-04-19 | Unilever Plc | Antibody fragment production |
DK0826054T3 (da) * | 1995-05-18 | 2004-04-19 | Genencor Int | Ekspression af glycosyltransferase i Aspergillus |
AU8437398A (en) | 1997-06-13 | 1998-12-30 | Unilever Plc | Bleaching enzymes |
EP0954978B1 (en) | 1998-03-12 | 2011-11-30 | VHsquared Limited | New products comprising inactivated yeasts or moulds provided with active antibodies |
ATE535154T1 (de) | 1998-03-12 | 2011-12-15 | Vhsquared Ltd | Produkten die inaktivierte hefen oder schimmel enthalten, die auf ihrer aussenoberfläche aktive antikörper haben |
AU6153100A (en) | 1999-07-27 | 2001-02-13 | Davis, Paul James | Bleaching detergent compositions |
EP1368380B1 (en) | 2000-12-19 | 2009-09-02 | Unilever N.V. | Stabilisation of heavy chain Camelid antibodies with potassium salts |
BR0307216A (pt) * | 2002-01-28 | 2005-12-20 | Medarex Inc | Anticorpos monoclonais humanos para antìgeno de membrana especìfica de próstata (psma) |
WO2006122787A1 (en) | 2005-05-18 | 2006-11-23 | Ablynx Nv | Serum albumin binding proteins |
KR101414438B1 (ko) | 2005-05-20 | 2014-07-10 | 아블린쓰 엔.브이. | 폰 빌레브란트 인자에 대한 단일 도메인 vhh 항체 |
EP2557090A3 (en) | 2006-12-19 | 2013-05-29 | Ablynx N.V. | Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
WO2008074840A2 (en) | 2006-12-19 | 2008-06-26 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
WO2008081031A2 (en) * | 2007-01-05 | 2008-07-10 | Novozymes A/S | Methods of increasing the production yield of a secreted antibody in a filamentous fungus by overexpression of the chaperone bip |
EP2260058A2 (en) | 2008-04-07 | 2010-12-15 | Ablynx N.V. | Single variable domains against the notch pathways |
CN102388069B (zh) | 2009-04-10 | 2016-01-20 | 埃博灵克斯股份有限公司 | 用于治疗il-6r相关疾病和病症的改进的针对il-6r的氨基酸序列和包含其的多肽 |
US9403898B2 (en) | 2009-05-07 | 2016-08-02 | Novozymes Biopharma Dk A/S | Method for purifying albumin |
RU2016103067A (ru) | 2009-06-05 | 2018-11-20 | Аблинкс Нв | Улучшенные аминокислотные последовательности, направленные против респираторно-синцитиального вируса человека (hrsv), и полипептиды, включающие такие последовательности, для профилактики и/или лечения инфекций дыхательных путей |
US9644022B2 (en) | 2009-11-30 | 2017-05-09 | Ablynx N.V. | Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
US8962807B2 (en) | 2009-12-14 | 2015-02-24 | Ablynx N.V. | Single variable domain antibodies against OX40L, constructs and therapeutic use |
WO2011083141A2 (en) | 2010-01-08 | 2011-07-14 | Ablynx Nv | Method for generation of immunoglobulin sequences by using lipoprotein particles |
US9120855B2 (en) | 2010-02-10 | 2015-09-01 | Novartis Ag | Biologic compounds directed against death receptor 5 |
WO2011117423A1 (en) | 2010-03-26 | 2011-09-29 | Ablynx N.V. | Immunoglobulin single variable domains directed against cxcr7 |
CN102906118B (zh) | 2010-05-20 | 2017-07-28 | 埃博灵克斯股份有限公司 | 与her3相关的生物材料 |
EP2621953B1 (en) | 2010-09-30 | 2017-04-05 | Ablynx N.V. | Biological materials related to c-met |
WO2012062713A1 (en) | 2010-11-08 | 2012-05-18 | Novartis Ag | Cxcr2 binding polypeptides |
US20150158948A9 (en) | 2011-03-28 | 2015-06-11 | Francis Descamps | Bispecific anti-cxcr7 immunoglobulin single variable domains |
UA117218C2 (uk) | 2011-05-05 | 2018-07-10 | Мерк Патент Гмбх | Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f |
CN104271598A (zh) | 2011-06-23 | 2015-01-07 | 埃博灵克斯股份有限公司 | 针对IgE的免疫球蛋白单可变结构域 |
CA2850261C (en) | 2011-09-30 | 2021-04-20 | Ablynx Nv | C-met immunoglobulin single variable domains |
US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
WO2014087010A1 (en) | 2012-12-07 | 2014-06-12 | Ablynx N.V. | IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE |
DK3071598T3 (da) | 2013-05-29 | 2021-09-13 | Vybion Inc | Enkeltkædede intrabodies, der ændrer nedbrydning af huntingtin-mutant |
NL2013661B1 (en) | 2014-10-21 | 2016-10-05 | Ablynx Nv | KV1.3 Binding immunoglobulins. |
WO2016097313A1 (en) | 2014-12-19 | 2016-06-23 | Ablynx N.V. | Cysteine linked nanobody dimers |
CN114920848A (zh) | 2015-05-13 | 2022-08-19 | 埃博灵克斯股份有限公司 | 基于cd3反应性的t细胞募集多肽 |
HUE045437T2 (hu) | 2015-05-13 | 2019-12-30 | Ablynx Nv | TCR-alfa-béta reaktivitásán alapulva T-sejtet toborzó polipeptidek |
WO2017013270A1 (en) | 2015-07-23 | 2017-01-26 | Universite De Strasbourg | Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy |
IL261188B (en) | 2016-03-04 | 2022-08-01 | Jn Biosciences Llc | An anti-tigit antibody that binds to the tigit polypeptide on one or more amino acid residues |
EP3526253A1 (en) | 2016-10-14 | 2019-08-21 | Institut Curie | New anti-lsp1 antibody |
WO2018091606A1 (en) | 2016-11-16 | 2018-05-24 | Ablynx Nv | T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta |
EP3624854A1 (en) | 2017-05-16 | 2020-03-25 | Université de Strasbourg | Protein-drug conjugates and their use in the treatment of cancers |
BR112019025097A2 (pt) | 2017-06-02 | 2020-07-28 | Merck Patent Gmbh | imunoglobulinas de ligação a mmp13 |
KR20200013247A (ko) | 2017-06-02 | 2020-02-06 | 아블린쓰 엔.브이. | 아그레칸 결합 면역글로불린 |
JP7249961B2 (ja) | 2017-06-02 | 2023-03-31 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Adamts5、mmp13およびアグリカンに結合するポリペプチド |
EP3630847A1 (en) | 2017-06-02 | 2020-04-08 | Merck Patent GmbH | Adamts binding immunoglobulins |
EP3658915A1 (en) | 2017-07-28 | 2020-06-03 | Institut Curie | New subpopulations of cancer associated fibroblasts as prognosis markers for immunotherapy treatments |
AR114269A1 (es) | 2018-02-26 | 2020-08-12 | Ablynx Nv | Secuencias nucleotídicas mejoradas que codifican para péptidos de unión |
KR101875564B1 (ko) * | 2018-05-24 | 2018-07-09 | 국민대학교산학협력단 | 포도당 및 글리세롤을 이용한 유가식 배양을 통한 리시놀레산으로 오메가-하이드록시운덱-9-에논산의 생물전환공정 |
EP3636657A1 (en) | 2018-10-08 | 2020-04-15 | Ablynx N.V. | Chromatography-free antibody purification method |
WO2020245663A1 (en) | 2019-06-01 | 2020-12-10 | Institut Pasteur | Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection |
MX2022015157A (es) | 2020-06-02 | 2023-01-16 | Arcus Biosciences Inc | Anticuerpos para tigit. |
EP4263610A1 (en) | 2020-12-18 | 2023-10-25 | Ablynx N.V. | T cell recruiting polypeptides based on tcr alpha/beta reactivity |
EP4337691A1 (en) | 2021-05-12 | 2024-03-20 | Université de Strasbourg | Single domain antibody specific for phosphorylated h2ax and its uses |
WO2023151894A1 (en) | 2022-02-11 | 2023-08-17 | Henkel Ag & Co. Kgaa | Process for the synthesis of alpha-methylene-gamma-butyrolactone |
US20240132624A1 (en) | 2022-07-27 | 2024-04-25 | Ablynx N.V. | Polypeptides binding to a specific epitope of the neonatal fc receptor |
WO2024083843A1 (en) | 2022-10-18 | 2024-04-25 | Confo Therapeutics N.V. | Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0539395A1 (en) * | 1990-07-16 | 1993-05-05 | Alko Group Ltd. | IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
WO1993008300A1 (en) * | 1991-10-18 | 1993-04-29 | The University Of Calgary | Expression-secretion vectors for the production of biologically active fv fragments |
IT1270866B (it) * | 1993-03-10 | 1997-05-13 | Eniricerche Spa | Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis |
-
1994
- 1994-06-09 DK DK94920443T patent/DK0702721T3/da active
- 1994-06-09 DE DE69426527T patent/DE69426527T2/de not_active Expired - Fee Related
- 1994-06-09 AT AT94920443T patent/ATE198490T1/de not_active IP Right Cessation
- 1994-06-09 JP JP7501340A patent/JPH08511160A/ja active Pending
- 1994-06-09 EP EP94920443A patent/EP0702721B1/en not_active Expired - Lifetime
- 1994-06-09 CA CA002162878A patent/CA2162878A1/en not_active Abandoned
- 1994-06-09 AU AU71234/94A patent/AU7123494A/en not_active Abandoned
- 1994-06-09 WO PCT/EP1994/001906 patent/WO1994029457A2/en active IP Right Grant
- 1994-06-09 ES ES94920443T patent/ES2155854T3/es not_active Expired - Lifetime
-
1995
- 1995-11-13 FI FI955446A patent/FI114870B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69426527D1 (de) | 2001-02-08 |
AU7123494A (en) | 1995-01-03 |
WO1994029457A2 (en) | 1994-12-22 |
EP0702721A1 (en) | 1996-03-27 |
DE69426527T2 (de) | 2001-08-30 |
FI114870B (fi) | 2005-01-14 |
JPH08511160A (ja) | 1996-11-26 |
DK0702721T3 (da) | 2001-05-21 |
CA2162878A1 (en) | 1994-12-22 |
FI955446A0 (fi) | 1995-11-13 |
FI955446A (fi) | 1995-12-11 |
EP0702721B1 (en) | 2001-01-03 |
ATE198490T1 (de) | 2001-01-15 |
WO1994029457A3 (en) | 1995-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2155854T3 (es) | Procedimiento de produccion de proteinas de fusion que comprende fragmentos de scfv con la ayuda de un molde transformado. | |
EP0042246B1 (en) | Plasmid | |
ATE97957T1 (de) | Verfahren zur herstellung des rekombinanten menschlichen faktors viii:c. | |
HUT46356A (en) | Process for producing the preprotein of apc polypeptide and the dna encoding it, as well as for the diagnostic utilization of the dna and the protein | |
DE69018920D1 (de) | Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine. | |
ATE177473T1 (de) | Herstellung von rekombinanten, menschlichem lactoferrin | |
CA2111238A1 (fr) | Production d'une proteine d'interet dans le lait d'un mammifere transgenique | |
PL321039A1 (en) | Production of human insulin | |
CA2123416A1 (en) | Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase ii gene | |
ATE233314T1 (de) | Eine sekretionssequenz für die herstellung von heterologen proteinen in hefe | |
HUT60712A (en) | Process for producing aspartame from diketopiperazine and process for producing intermediates | |
PL309882A1 (en) | Dna sequence encoding novel biosynthetic insulin precursors and insulin obtaining method | |
EP0261625A3 (en) | Human b-cell differentiation factor and process of producing said factor | |
HUP9802915A2 (hu) | Új sztafilokinázszármazékok | |
ATE224403T1 (de) | Verwendung von kaseinfragmenten als wachstumerförderer | |
AU1003797A (en) | Novel HS gene, expression plasmid in which HS gene is ligated downstream of structural gene encoding foreign gene PR product, and process for producing foreign gene product using transformant containing the expression of plasmid | |
IE883018L (en) | Expression of transforming growth factor b2 | |
DE3573256D1 (en) | (6,11-dihydro-11-oxodibenz(b,e)oxepinyl)pentanoic acids and derivatives, a process and intermediates for their preparation and their use as medicaments | |
JPS6474989A (en) | Dna to code human lysozyme | |
EP0184163A3 (de) | Herstellung eines Multi-Kopien-Hefe-Vektors | |
MX9800686A (es) | Nueva proteina hmw humana mp52s. | |
WO2000040603A3 (en) | Production of recombinant monellin using methylotrophic yeast expression system | |
IT1228550B (it) | Procedimento per la fabbricazione dell'acido 7-d(-)-a-amino-a- (p-idrossifenil)acetamido -3-(1h-1,2,3-triazol-5-il) tiometil-3-cefem -4-carbossilico 1,2-propilenglicolato e intermedi relativi | |
HUT63862A (en) | Process for producing collagen | |
CS541887A1 (en) | Method of chalazion hydrolysate production for cosmetical and pharmaceutical purposes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 702721 Country of ref document: ES |